Neupath Health Stock Market Value
| NPTH Stock | CAD 0.19 0.01 5.56% |
| Symbol | NeuPath |
NeuPath Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NeuPath Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NeuPath Health.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in NeuPath Health on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding NeuPath Health or generate 0.0% return on investment in NeuPath Health over 90 days. NeuPath Health is related to or competes with Thunderbird Entertainment, Plantify Foods, Canlan Ice, MTY Food, Goodfood Market, and Algoma Steel. NeuPath Health Inc. provides chronic pain management services in Canada More
NeuPath Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NeuPath Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NeuPath Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.91 | |||
| Information Ratio | 0.0443 | |||
| Maximum Drawdown | 15.79 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 5.56 |
NeuPath Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeuPath Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NeuPath Health's standard deviation. In reality, there are many statistical measures that can use NeuPath Health historical prices to predict the future NeuPath Health's volatility.| Risk Adjusted Performance | 0.0246 | |||
| Jensen Alpha | 0.1951 | |||
| Total Risk Alpha | 0.5634 | |||
| Sortino Ratio | 0.0358 | |||
| Treynor Ratio | 0.0566 |
NeuPath Health Backtested Returns
NeuPath Health has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. NeuPath Health exposes twenty-seven different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NeuPath Health's Downside Deviation of 4.91, risk adjusted performance of 0.0246, and Mean Deviation of 2.86 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NeuPath Health will likely underperform. At this point, NeuPath Health has a negative expected return of -0.0156%. Please make sure to verify NeuPath Health's treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to decide if NeuPath Health performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.52 |
Good reverse predictability
NeuPath Health has good reverse predictability. Overlapping area represents the amount of predictability between NeuPath Health time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NeuPath Health price movement. The serial correlation of -0.52 indicates that about 52.0% of current NeuPath Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.52 | |
| Spearman Rank Test | -0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NeuPath Health lagged returns against current returns
Autocorrelation, which is NeuPath Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NeuPath Health's stock expected returns. We can calculate the autocorrelation of NeuPath Health returns to help us make a trade decision. For example, suppose you find that NeuPath Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NeuPath Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NeuPath Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NeuPath Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NeuPath Health stock over time.
Current vs Lagged Prices |
| Timeline |
NeuPath Health Lagged Returns
When evaluating NeuPath Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NeuPath Health stock have on its future price. NeuPath Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NeuPath Health autocorrelation shows the relationship between NeuPath Health stock current value and its past values and can show if there is a momentum factor associated with investing in NeuPath Health.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.